Joyvié Health Raises $1.04M to Redesign Continence Care

Jan de Vries · 2026-06-05

Joyvié Health, a UK-based startup, has closed its pre-Seed funding round at $1.04 million (€897k). The company is rethinking continence underwear from the ground up. Their goal? Cut stool-to-skin contact, protect skin integrity, and lighten the load for caregivers. ### The Funding Details The round combines an Innovate UK grant with investments from HERmesa Angels, SyndicateRoom, Lavender Ventures, and several angel investors. That mix of public and private backing shows how much this space needs fresh thinking. “Products designed for care should never cause harm. That’s not a vision statement. It’s the reason this company exists,” says Zoe Robson, Founder & CEO of Joyvié Health.  ### Why This Matters Now Joyvié Health isn't alone in the 2026 HealthTech funding boom. Across the UK and Europe, over $181 million (€173 million) has flowed into adjacent areas like elderly care, medical devices, and women's health. For example: - Semble raised $36.1 million (€34.7 million) for outpatient healthcare management. - Evaro secured $21.8 million (€21 million) to expand NHS-licensed health services. - Recare in Berlin got $38.5 million (€37 million) for its AI hospital platform. This wave of investment signals a shift. Investors are betting big on tech that improves care delivery and patient dignity. ### The Personal Story Behind the Startup Joyvié Health was born from loss. Zoe Robson’s father, Fred, was 77—fit and sharp—when he got a late-stage pancreatic cancer diagnosis on Christmas Eve 2024. Eleven weeks later, he was gone. In those weeks, Fred lost bowel control and had to wear adult nappies. Feces trapped against skin causes breakdown—moisture, pathogens, and pH imbalance do damage that never fully heals. His skin broke down. His dignity slipped away with every change. And Ruth, his wife and primary caregiver, carried an invisible burden. “My parents didn’t deserve that,” says Zoe. “They were both at their most vulnerable—and the product meant to help them was making it worse. The skin breakdown, the shame, the loss of dignity, the weight on my mum. It wasn’t from lack of care. It’s a design failure.” ### How Joyvié’s Product Works Traditional adult nappies and pads trap stool against the skin—a design unchanged for decades. Joyvié’s underwear contains stool in a disposable pouch right after excretion. Early tests show about 90% less stool-to-skin contact and changes that are roughly 70% faster. That means less skin damage, more dignity, and less time spent on cleanup for caregivers. ### A Bigger Problem Than Most Realize Faecal incontinence affects an estimated 656 million people worldwide. Yet the most common non-invasive solution hasn’t evolved. Joyvié wants to end that silent humiliation. “At Lavender Ventures, we are committed to backing founders addressing large, underserved markets with innovative solutions that can meaningfully improve people’s lives,” says Gail Armstrong of Lavender Ventures. “We believe the market is ripe for innovation, and Joyvié’s approach has the potential to deliver significant benefits not only for individuals, but also for carers, healthcare systems and the environment.” ### What’s Next With this funding, Joyvié plans to refine its product, run more tests, and bring it to market. The company is part of a larger HealthTech push—one that’s finally treating care products with the seriousness they deserve.